Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Transplantation. 2021 Dec 1;105(12):e303–e321. doi: 10.1097/TP.0000000000003765

Figure 2.

Figure 2.

Simplified overview of hematopoietic or mesenchymal derived cells which have important effector and regulatory roles in transplant immunology – with potential candidates for tolerogenic cell therapy for clinical transplant tolerance highlighted (dotted boxes). BReg, regulatory B cell; DC, dendritic cell; Mreg, regulatory macrophage; NK, natural killer; TolDC, tolerogenic dendritic cell; Treg, regulatory T cell.